Skip to main content

For adults with active non-radiographic axial spondyloarthritis

Purple to pink gradient background

The first and only treatment to offer both self-injection and IV infusion dosing options that target IL-17A.

If you have any questions about your condition or how to take COSENTYX, talk to your doctor to decide if COSENTYX is right for you.

*Limitations apply. Valid only for those with private insurance. Program provides up to $16,000 annually for the cost of COSENTYX and up to $150 per infusion (up to $1,950 annually) for the cost of administration. Co-pay support for infusion administration cost not available in Rhode Island or Massachusetts. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.